Concepedia

Publication | Open Access

ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy

94

Citations

30

References

2016

Year

Abstract

Longitudinal gene-panel ctDNA sequencing could be exploited to determine resistance and guide the precise administration of anti-HER2 targeted therapy in the metastatic setting.

References

YearCitations

Page 1